Original Research
Accepted on 21 Apr 2025
Population pharmacokinetic analysis of rivaroxaban in healthy volunteers and patients with radiofrequency ablation of non-valvular atrial fibrillation in China
in Cardiovascular and Smooth Muscle Pharmacology